Management of salivary gland adenoid cystic carcinoma
institutional experience of a case series
Keywords:
Head and neck cancer, Salivary gland neoplasms, Adenoid cystic carcinoma, Neoplasm staging, RadiotherapyAbstract
CONTEXT AND OBJECTIVE: Salivary gland tumor management requires long-term follow-up because of tumor indolence and possible late recurrence and distant metastasis. Adenoid cystic carcinoma (ACC) accounts for 10-15% of such tumors. The aim here was to evaluate surgical and clinical management, staging and follow-up of ACC patients in one academic institution. DESIGN AND SETTING: Retrospective study at Head and Neck Service, Universidade Estadual de Campinas. METHODS: Data on 21 patients treated between 1993 and 2003 were reviewed. Management utilized clinical staging, histology and imaging. Major salivary gland tumor extent was routinely assessed by preoperative ultrasonography. Diag- nosis, surgery type, margin type (negative/posi- tive), postoperative radiotherapy and recurrence (presence/absence) were evaluated. RESULTS: There were eleven major salivary gland tumors (52.3%), seven submandibular and four parotid. Ten patients (47.7%) had minor salivary gland ACC (all in palate), while the submandibular was the most frequently affected major one. Diagnoses were mostly via fine-needle aspiration (FNA) and incision biopsy. Frozen sec- tions were used for six patients. There was good ultrasound/FNA correlation. Sixteen (76%) had postoperative radiotherapy. One (4.7%) died from ACC and five now have recurrent disease: three (14.2%) locoregional and two (9.5%) distant metastases. CONCLUSION: Adenoid cystic carcinoma has locally aggressive behavior. In 21 cases, of ACC, the facial nerve was preserved in all except in the few with gross tumor involvement. Treatment was defined from physical examination, imaging, staging and histology.
Downloads
References
Chummun S, McLean NR, Kelly CG, et al. Adenoid cystic carcinoma of the head and neck. Br J Plast Surg. 2001;54(6):476-80.
Khan AJ, DiGiovanna MP, Ross DA, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer. 2001;96(3):149-58.
Matsuba HM, Thawley SE, Simpson JR, Levine LA, Mauney M. Adenoid cystic carcinoma of major and minor salivary gland origin. Laryngoscope. 1984;94(10):1316-8.
Nascimento AG, Amaral AL, Prado LA, Kligerman J, Sil- veira TR. Adenoid cystic carcinoma of salivary glands. A study of 61 cases with clinicopathologic correlation. Cancer. 1986;57(2):312-9.
Seaver PR Jr, Kuehn PG. Adenoid cystic carcinoma of the salivary glands. A study of ninety-three cases. Am J Surg. 1979;137(4):449-55.
Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg. 1992;164(6):623-8.
Simpson JR, Thawley SE, Matsuba HM. Adenoid cystic salivary gland carcinoma: treatment with irradiation and surgery. Radiol- ogy. 1984;151(2):509-12.
Conley J, Hamaker RC. Prognosis of malignant tumors of the parotid gland with facial paralysis. Arch Otolaryngol. 1975;101(1):39-41.
Bradley PJ. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg. 2004;12(2):127-32.
Eneroth CM. Facial nerve paralysis. A criterion of malignancy in parotid tumors. Arch Otolaryngol. 1972;95(4):300-4.
Mendenhall WM, Morris CG, Amdur RJ, Werning JW, Hiner- man RW, Villaret DB. Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck. 2004;26(2):154-62.
Fordice J, Kershaw C, El-Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of mor- bidity and mortality. Arch Otolaryngol Head Neck Surg. 1999;125(2):149-52.
Spiro RH. Management of malignant tumors of the salivary glands. Oncology (Williston Park). 1998;12(5):671-80; discus- sion 683.
Medina JE. Neck dissection in the treatment of cancer of major salivary glands. Otolaryngol Clin North Am. 1998;31(5):815-22.